PMC:7205724 / 28043-29432
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1027 | 746-749 | Gene | denotes | Rp3 | Gene:22924 |
| 1028 | 886-889 | Gene | denotes | Rp3 | Gene:22924 |
| 1029 | 281-289 | Species | denotes | patients | Tax:9606 |
| 1030 | 347-356 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1031 | 388-396 | Species | denotes | patients | Tax:9606 |
| 1032 | 425-433 | Species | denotes | SARS-CoV | Tax:694009 |
| 1033 | 438-447 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1034 | 598-605 | Species | denotes | rabbits | Tax:9986 |
| 1035 | 654-663 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1036 | 727-738 | Species | denotes | coronavirus | Tax:11118 |
| 1037 | 742-745 | Species | denotes | CoV | Tax:11118 |
| 1038 | 882-885 | Species | denotes | CoV | Tax:11118 |
| 1039 | 901-910 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1040 | 1008-1015 | Species | denotes | patient | Tax:9606 |
| 1041 | 1061-1070 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1042 | 1368-1375 | Species | denotes | patient | Tax:9606 |
| 1043 | 574-582 | Species | denotes | patients | Tax:9606 |
| 1044 | 1205-1213 | Species | denotes | patients | Tax:9606 |
| 1045 | 32-40 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1046 | 305-313 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1047 | 409-417 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T204 | 236-242 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T205 | 269-275 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T206 | 493-497 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T207 | 545-550 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T208 | 587-592 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T209 | 686-691 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T210 | 1054-1057 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T211 | 1148-1151 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T212 | 1156-1159 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T34 | 545-550 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T35 | 587-592 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T36 | 686-691 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T209 | 32-40 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T210 | 305-313 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T211 | 347-351 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T212 | 409-417 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T213 | 425-433 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T214 | 438-442 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T215 | 569-573 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T216 | 621-625 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T217 | 654-658 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T218 | 717-721 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T219 | 901-905 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T220 | 1061-1065 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T323 | 236-242 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T324 | 269-275 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
| T325 | 357-360 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T326 | 493-497 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T327 | 697-701 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bats |
| T328 | 795-796 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T329 | 836-838 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T330 | 853-855 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T331 | 875-878 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
| T332 | 912-913 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T233 | 739-741 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
| T234 | 879-881 | Chemical | denotes | SL | http://purl.obolibrary.org/obo/CHEBI_74815 |
| T235 | 978-993 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T141 | 493-497 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
| T142 | 1296-1303 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T149 | 978-993 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T150 | 1054-1057 | Chemical | denotes | RNA | http://purl.obolibrary.org/obo/CHEBI_33697 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T255 | 32-40 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T256 | 305-313 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T257 | 347-356 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T258 | 409-417 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T259 | 425-433 | Species | denotes | SARS-CoV | NCBItxid:694009 |
| T260 | 438-447 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T261 | 569-573 | Species | denotes | SARS | NCBItxid:694009 |
| T262 | 598-605 | Species | denotes | rabbits | NCBItxid:9986 |
| T263 | 621-625 | Species | denotes | SARS | NCBItxid:694009 |
| T264 | 654-663 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T265 | 697-701 | Species | denotes | bats | NCBItxid:9397 |
| T266 | 717-721 | Species | denotes | SARS | NCBItxid:694009 |
| T267 | 722-726 | Species | denotes | lice | NCBItxid:85819 |
| T268 | 875-878 | Species | denotes | bat | NCBItxid:9397 |
| T269 | 901-910 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T270 | 1061-1070 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T227 | 0-196 | Sentence | denotes | Lack of specific treatments for COVID-19 and the very time-consuming process of vaccine development lead us to trust traditional notions of immunization using passive transfer of humoral immunity. |
| T228 | 197-268 | Sentence | denotes | Passive immunization can be done using plasma therapy and IVIG therapy. |
| T229 | 269-418 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
| T230 | 419-526 | Sentence | denotes | Also, SARS-CoV and SARS-CoV2 are ideally similar in the structure and the cell entry receptor and protease. |
| T231 | 527-676 | Sentence | denotes | Studies show that serum from convalescent SARS patients and serum from rabbits immunized with SARS are both able to neutralize SARS-CoV2 efficiently. |
| T232 | 677-781 | Sentence | denotes | However, serum from bats immunized with SARS-lice coronavirus SL-CoV Rp3 could not exert such an effect. |
| T233 | 782-911 | Sentence | denotes | It is due to a noticeable degree of difference in the S1 domain in the S1 domain between the bat SL-CoV Rp3 strain and SARS-CoV2. |
| T234 | 912-1025 | Sentence | denotes | A short-term moderate dose of IVIG combined with moderate-dose of corticosteroids might improve patient outcomes. |
| T235 | 1026-1257 | Sentence | denotes | Studies show that the viral RNA of SARS-CoV2 reaches its peak during the first week and then gradually decreases and that IgG and IgM begin to rise from the 10th day so that most patients have anti-viral antibodies by the 14th day. |
| T236 | 1258-1389 | Sentence | denotes | Passive immunization protects against disease, and so it should be administered as early as possible when the patient is diagnosed. |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T34 | 545-550 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T35 | 587-592 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T36 | 686-691 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1045 | 32-40 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1029 | 281-289 | Species | denotes | patients | Tax:9606 |
| 1046 | 305-313 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1030 | 347-356 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1031 | 388-396 | Species | denotes | patients | Tax:9606 |
| 1047 | 409-417 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1032 | 425-433 | Species | denotes | SARS-CoV | Tax:694009 |
| 1033 | 438-447 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1043 | 574-582 | Species | denotes | patients | Tax:9606 |
| 1034 | 598-605 | Species | denotes | rabbits | Tax:9986 |
| 1035 | 654-663 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1036 | 727-738 | Species | denotes | coronavirus | Tax:11118 |
| 1037 | 742-745 | Species | denotes | CoV | Tax:11118 |
| 1027 | 746-749 | Gene | denotes | Rp3 | Gene:22924 |
| 1038 | 882-885 | Species | denotes | CoV | Tax:11118 |
| 1028 | 886-889 | Gene | denotes | Rp3 | Gene:22924 |
| 1039 | 901-910 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1040 | 1008-1015 | Species | denotes | patient | Tax:9606 |
| 1041 | 1061-1070 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 1044 | 1205-1213 | Species | denotes | patients | Tax:9606 |
| 1042 | 1368-1375 | Species | denotes | patient | Tax:9606 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T2913 | 517-525 | Protein | denotes | protease | https://www.uniprot.org/uniprot/Q9Y6I0|https://www.uniprot.org/uniprot/Q9WJC5|https://www.uniprot.org/uniprot/Q9WF19|https://www.uniprot.org/uniprot/Q9WC63|https://www.uniprot.org/uniprot/Q9WC54|https://www.uniprot.org/uniprot/Q9UKI1|https://www.uniprot.org/uniprot/Q9UKI0|https://www.uniprot.org/uniprot/Q9UKH6|https://www.uniprot.org/uniprot/Q9UKH5|https://www.uniprot.org/uniprot/P04323|https://www.uniprot.org/uniprot/P04023|https://www.uniprot.org/uniprot/P03371|https://www.uniprot.org/uniprot/P03370|https://www.uniprot.org/uniprot/P03369|https://www.uniprot.org/uniprot/P03368|https://www.uniprot.org/uniprot/P03367|https://www.uniprot.org/uniprot/P03366|https://www.uniprot.org/uniprot/P03365|https://www.uniprot.org/uniprot/P03363|https://www.uniprot.org/uniprot/P03362|https://www.uniprot.org/uniprot/P03361|https://www.uniprot.org/uniprot/P03360|https://www.uniprot.org/uniprot/P03359|https://www.uniprot.org/uniprot/P03357|https://www.uniprot.org/uniprot/P03356|https://www.uniprot.org/uniprot/P03355|https://www.uniprot.org/uniprot/P03353|https://www.uniprot.org/uniprot/P03253|https://www.uniprot.org/uniprot/P03252|https://www.uniprot.org/uniprot/P03234|https://www.uniprot.org/uniprot/O93215|https://www.uniprot.org/uniprot/O92808|https://www.uniprot.org/uniprot/O91080|https://www.uniprot.org/uniprot/O89940|https://www.uniprot.org/uniprot/O89811|https://www.uniprot.org/uniprot/O89290|https://www.uniprot.org/uniprot/O73194|https://www.uniprot.org/uniprot/O71150|https://www.uniprot.org/uniprot/O71070|https://www.uniprot.org/uniprot/O56228|https://www.uniprot.org/uniprot/O56227|https://www.uniprot.org/uniprot/O41798|https://www.uniprot.org/uniprot/O40958|https://www.uniprot.org/uniprot/O36367|https://www.uniprot.org/uniprot/O12158|https://www.uniprot.org/uniprot/O09798|https://www.uniprot.org/uniprot/O09777|https://www.uniprot.org/uniprot/D2K3N9|https://www.uniprot.org/uniprot/D2K3N8|https://www.uniprot.org/uniprot/D0UZM9|https://www.uniprot.org/uniprot/A0A0U3TYK5|https://www.uniprot.org/uniprot/A0A0A8IBU6|https://www.uniprot.org/uniprot/Q9UKH4|https://www.uniprot.org/uniprot/Q9QSR3|https://www.uniprot.org/uniprot/Q9QM72|https://www.uniprot.org/uniprot/Q9QJ30|https://www.uniprot.org/uniprot/Q9QBZ9|https://www.uniprot.org/uniprot/Q9QBZ5|https://www.uniprot.org/uniprot/Q9QBZ1|https://www.uniprot.org/uniprot/Q9QBY3|https://www.uniprot.org/uniprot/Q9Q720|https://www.uniprot.org/uniprot/Q9IZT3|https://www.uniprot.org/uniprot/Q9IZT2|https://www.uniprot.org/uniprot/Q9IRA3|https://www.uniprot.org/uniprot/Q9IIH4|https://www.uniprot.org/uniprot/Q9IDV9|https://www.uniprot.org/uniprot/Q9E6P2|https://www.uniprot.org/uniprot/Q9E6P1|https://www.uniprot.org/uniprot/Q96629|https://www.uniprot.org/uniprot/Q91QZ3|https://www.uniprot.org/uniprot/Q8JN66|https://www.uniprot.org/uniprot/Q8I7P9|https://www.uniprot.org/uniprot/Q8AII1|https://www.uniprot.org/uniprot/Q89928|https://www.uniprot.org/uniprot/Q89855|https://www.uniprot.org/uniprot/Q89703|https://www.uniprot.org/uniprot/Q89548|https://www.uniprot.org/uniprot/Q88140|https://www.uniprot.org/uniprot/Q85590|https://www.uniprot.org/uniprot/Q85571|https://www.uniprot.org/uniprot/Q85570|https://www.uniprot.org/uniprot/Q84177|https://www.uniprot.org/uniprot/Q83906|https://www.uniprot.org/uniprot/Q83417|https://www.uniprot.org/uniprot/Q82859|https://www.uniprot.org/uniprot/Q82851|https://www.uniprot.org/uniprot/Q7SVK7|https://www.uniprot.org/uniprot/Q7M6L1|https://www.uniprot.org/uniprot/Q7M6L0|https://www.uniprot.org/uniprot/Q79666|https://www.uniprot.org/uniprot/Q79582|https://www.uniprot.org/uniprot/Q77906|https://www.uniprot.org/uniprot/Q777B6|https://www.uniprot.org/uniprot/Q77373|https://www.uniprot.org/uniprot/Q76634|https://www.uniprot.org/uniprot/Q76629|https://www.uniprot.org/uniprot/Q76605|https://www.uniprot.org/uniprot/Q75002|https://www.uniprot.org/uniprot/Q74120|https://www.uniprot.org/uniprot/Q73368|https://www.uniprot.org/uniprot/Q6UDK6|https://www.uniprot.org/uniprot/Q6UDK5|https://www.uniprot.org/uniprot/Q6SW62|https://www.uniprot.org/uniprot/Q6SW61|https://www.uniprot.org/uniprot/Q6S6T7|https://www.uniprot.org/uniprot/Q6S6T6|https://www.uniprot.org/uniprot/Q69263|https://www.uniprot.org/uniprot/Q69030|https://www.uniprot.org/uniprot/Q66541|https://www.uniprot.org/uniprot/Q65ZF9|https://www.uniprot.org/uniprot/Q65652|https://www.uniprot.org/uniprot/Q65593|https://www.uniprot.org/uniprot/Q64962|https://www.uniprot.org/uniprot/Q61577|https://www.uniprot.org/uniprot/Q5TJ03|https://www.uniprot.org/uniprot/Q4U0X6|https://www.uniprot.org/uniprot/Q3KSP9|https://www.uniprot.org/uniprot/Q2Q1R2|https://www.uniprot.org/uniprot/Q2HRB6|https://www.uniprot.org/uniprot/Q2HRB5|https://www.uniprot.org/uniprot/Q27YG9|https://www.uniprot.org/uniprot/Q1HVC7|https://www.uniprot.org/uniprot/Q18LE3|https://www.uniprot.org/uniprot/Q0R5R3|https://www.uniprot.org/uniprot/Q0R5R2|https://www.uniprot.org/uniprot/Q09SZ9|https://www.uniprot.org/uniprot/Q02836|https://www.uniprot.org/uniprot/Q01002|https://www.uniprot.org/uniprot/P90341|https://www.uniprot.org/uniprot/P89449|https://www.uniprot.org/uniprot/P87563|https://www.uniprot.org/uniprot/P84454|https://www.uniprot.org/uniprot/P68986|https://www.uniprot.org/uniprot/P68985|https://www.uniprot.org/uniprot/P68984|https://www.uniprot.org/uniprot/P63131|https://www.uniprot.org/uniprot/P63129|https://www.uniprot.org/uniprot/P63128|https://www.uniprot.org/uniprot/P63127|https://www.uniprot.org/uniprot/P63125|https://www.uniprot.org/uniprot/P63124|https://www.uniprot.org/uniprot/P63123|https://www.uniprot.org/uniprot/P63122|https://www.uniprot.org/uniprot/P63121|https://www.uniprot.org/uniprot/P63120|https://www.uniprot.org/uniprot/P63119|https://www.uniprot.org/uniprot/P54817|https://www.uniprot.org/uniprot/P52369|https://www.uniprot.org/uniprot/P52351|https://www.uniprot.org/uniprot/P42672|https://www.uniprot.org/uniprot/P35990|https://www.uniprot.org/uniprot/P35963|https://www.uniprot.org/uniprot/P35956|https://www.uniprot.org/uniprot/P33459|https://www.uniprot.org/uniprot/P32542|https://www.uniprot.org/uniprot/P31822|https://www.uniprot.org/uniprot/P30202|https://www.uniprot.org/uniprot/P28936|https://www.uniprot.org/uniprot/P27980|https://www.uniprot.org/uniprot/P27973|https://www.uniprot.org/uniprot/P27528|https://www.uniprot.org/uniprot/P27502|https://www.uniprot.org/uniprot/P26810|https://www.uniprot.org/uniprot/P26809|https://www.uniprot.org/uniprot/P26808|https://www.uniprot.org/uniprot/P25059|https://www.uniprot.org/uniprot/P24740|https://www.uniprot.org/uniprot/P24433|https://www.uniprot.org/uniprot/P24107|https://www.uniprot.org/uniprot/P23984|https://www.uniprot.org/uniprot/P23427|https://www.uniprot.org/uniprot/P23426|https://www.uniprot.org/uniprot/P22382|https://www.uniprot.org/uniprot/P21414|https://www.uniprot.org/uniprot/P20892|https://www.uniprot.org/uniprot/P20876|https://www.uniprot.org/uniprot/P20875|https://www.uniprot.org/uniprot/P20825|https://www.uniprot.org/uniprot/P19561|https://www.uniprot.org/uniprot/P19560|https://www.uniprot.org/uniprot/P19505|https://www.uniprot.org/uniprot/P19202|https://www.uniprot.org/uniprot/P19199|https://www.uniprot.org/uniprot/P19151|https://www.uniprot.org/uniprot/P19119|https://www.uniprot.org/uniprot/P19028|https://www.uniprot.org/uniprot/P18802|https://www.uniprot.org/uniprot/P18096|https://www.uniprot.org/uniprot/P18042|https://www.uniprot.org/uniprot/P17965|https://www.uniprot.org/uniprot/P17757|https://www.uniprot.org/uniprot/P17283|https://www.uniprot.org/uniprot/P16901|https://www.uniprot.org/uniprot/P16753|https://www.uniprot.org/uniprot/P16423|https://www.uniprot.org/uniprot/P16088|https://www.uniprot.org/uniprot/P16046|https://www.uniprot.org/uniprot/P15833|https://www.uniprot.org/uniprot/P14078|https://www.uniprot.org/uniprot/P14074|https://www.uniprot.org/uniprot/P12502|https://www.uniprot.org/uniprot/P12499|https://www.uniprot.org/uniprot/P12498|https://www.uniprot.org/uniprot/P12497|https://www.uniprot.org/uniprot/P12451|https://www.uniprot.org/uniprot/P11826|https://www.uniprot.org/uniprot/P11825|https://www.uniprot.org/uniprot/P11365|https://www.uniprot.org/uniprot/P11283|https://www.uniprot.org/uniprot/P11227|https://www.uniprot.org/uniprot/P11204|https://www.uniprot.org/uniprot/P10394|https://www.uniprot.org/uniprot/P10381|https://www.uniprot.org/uniprot/P10274|https://www.uniprot.org/uniprot/P10273|https://www.uniprot.org/uniprot/P10272|https://www.uniprot.org/uniprot/P10271|https://www.uniprot.org/uniprot/P10270|https://www.uniprot.org/uniprot/P10265|https://www.uniprot.org/uniprot/P10210|https://www.uniprot.org/uniprot/P0DOI1|https://www.uniprot.org/uniprot/P0DOI0|https://www.uniprot.org/uniprot/P0C6F2|https://www.uniprot.org/uniprot/P0C211|https://www.uniprot.org/uniprot/P0C210|https://www.uniprot.org/uniprot/P09569|https://www.uniprot.org/uniprot/P09286|https://www.uniprot.org/uniprot/P08361|https://www.uniprot.org/uniprot/P07885|https://www.uniprot.org/uniprot/P05962|https://www.uniprot.org/uniprot/P05961|https://www.uniprot.org/uniprot/P05960|https://www.uniprot.org/uniprot/P05959|https://www.uniprot.org/uniprot/P05897|https://www.uniprot.org/uniprot/P05896|https://www.uniprot.org/uniprot/P05895|https://www.uniprot.org/uniprot/P04589|https://www.uniprot.org/uniprot/P04588|https://www.uniprot.org/uniprot/P04587|https://www.uniprot.org/uniprot/P04585|https://www.uniprot.org/uniprot/P04584|https://www.uniprot.org/uniprot/Q1HVC6|https://www.uniprot.org/uniprot/Q1A267|https://www.uniprot.org/uniprot/Q1A249 |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2209 | 0-4 | NN | denotes | Lack |
| T82418 | 5-7 | IN | denotes | of |
| T17483 | 8-16 | JJ | denotes | specific |
| T11435 | 17-27 | NNS | denotes | treatments |
| T58860 | 28-31 | IN | denotes | for |
| T97288 | 32-40 | NN | denotes | COVID-19 |
| T14954 | 41-44 | CC | denotes | and |
| T67635 | 45-48 | DT | denotes | the |
| T14560 | 49-53 | RB | denotes | very |
| T29994 | 54-68 | JJ | denotes | time-consuming |
| T54347 | 69-76 | NN | denotes | process |
| T43425 | 77-79 | IN | denotes | of |
| T40405 | 80-87 | NN | denotes | vaccine |
| T65584 | 88-99 | NN | denotes | development |
| T26632 | 100-104 | VBP | denotes | lead |
| T87212 | 105-107 | PRP | denotes | us |
| T4319 | 108-110 | TO | denotes | to |
| T17398 | 111-116 | VB | denotes | trust |
| T39922 | 117-128 | JJ | denotes | traditional |
| T59832 | 129-136 | NNS | denotes | notions |
| T79640 | 137-139 | IN | denotes | of |
| T39982 | 140-152 | NN | denotes | immunization |
| T68886 | 153-158 | VBG | denotes | using |
| T59526 | 159-166 | JJ | denotes | passive |
| T93112 | 167-175 | NN | denotes | transfer |
| T2403 | 176-178 | IN | denotes | of |
| T97514 | 179-186 | JJ | denotes | humoral |
| T67166 | 187-195 | NN | denotes | immunity |
| T8460 | 197-204 | JJ | denotes | Passive |
| T78989 | 205-217 | NN | denotes | immunization |
| T37380 | 218-221 | MD | denotes | can |
| T3292 | 222-224 | VB | denotes | be |
| T87394 | 225-229 | VBN | denotes | done |
| T83285 | 230-235 | VBG | denotes | using |
| T80590 | 236-242 | NN | denotes | plasma |
| T40394 | 243-250 | NN | denotes | therapy |
| T28898 | 251-254 | CC | denotes | and |
| T56173 | 255-259 | NN | denotes | IVIG |
| T89662 | 260-267 | NN | denotes | therapy |
| T43126 | 269-275 | NN | denotes | Plasma |
| T98086 | 276-280 | IN | denotes | from |
| T4913 | 281-289 | NNS | denotes | patients |
| T85558 | 290-299 | VBN | denotes | recovered |
| T54139 | 300-304 | IN | denotes | from |
| T65005 | 305-313 | NN | denotes | COVID-19 |
| T70575 | 314-318 | WDT | denotes | that |
| T50076 | 319-327 | VBZ | denotes | contains |
| T23714 | 328-338 | NNS | denotes | antibodies |
| T54709 | 339-346 | IN | denotes | against |
| T26763 | 347-356 | NN | denotes | SARS-CoV2 |
| T82790 | 357-360 | VBZ | denotes | has |
| T72786 | 361-366 | VBN | denotes | shown |
| T96449 | 367-376 | JJ | denotes | promising |
| T61880 | 377-384 | NNS | denotes | results |
| T36158 | 385-387 | IN | denotes | in |
| T98710 | 388-396 | NNS | denotes | patients |
| T52661 | 397-401 | IN | denotes | with |
| T93981 | 402-408 | JJ | denotes | severe |
| T61440 | 409-417 | NN | denotes | COVID-19 |
| T56097 | 419-423 | RB | denotes | Also |
| T27399 | 423-424 | -COMMA- | denotes | , |
| T46672 | 425-433 | NN | denotes | SARS-CoV |
| T4016 | 434-437 | CC | denotes | and |
| T5488 | 438-447 | NN | denotes | SARS-CoV2 |
| T49089 | 448-451 | VBP | denotes | are |
| T63728 | 452-459 | RB | denotes | ideally |
| T58020 | 460-467 | JJ | denotes | similar |
| T17353 | 468-470 | IN | denotes | in |
| T77583 | 471-474 | DT | denotes | the |
| T84845 | 475-484 | NN | denotes | structure |
| T63353 | 485-488 | CC | denotes | and |
| T19500 | 489-492 | DT | denotes | the |
| T16312 | 493-497 | NN | denotes | cell |
| T15071 | 498-503 | NN | denotes | entry |
| T65845 | 504-512 | NN | denotes | receptor |
| T64776 | 513-516 | CC | denotes | and |
| T5365 | 517-525 | NN | denotes | protease |
| T91360 | 527-534 | NNS | denotes | Studies |
| T61175 | 535-539 | VBP | denotes | show |
| T3464 | 540-544 | IN | denotes | that |
| T71594 | 545-550 | NN | denotes | serum |
| T59411 | 551-555 | IN | denotes | from |
| T50943 | 556-568 | JJ | denotes | convalescent |
| T99070 | 569-573 | NN | denotes | SARS |
| T52714 | 574-582 | NNS | denotes | patients |
| T30344 | 583-586 | CC | denotes | and |
| T97752 | 587-592 | NN | denotes | serum |
| T56749 | 593-597 | IN | denotes | from |
| T81227 | 598-605 | NNS | denotes | rabbits |
| T65088 | 606-615 | VBN | denotes | immunized |
| T9531 | 616-620 | IN | denotes | with |
| T3496 | 621-625 | NNS | denotes | SARS |
| T18753 | 626-629 | VBP | denotes | are |
| T56305 | 630-634 | DT | denotes | both |
| T22390 | 635-639 | JJ | denotes | able |
| T89303 | 640-642 | TO | denotes | to |
| T72802 | 643-653 | VB | denotes | neutralize |
| T57194 | 654-663 | NN | denotes | SARS-CoV2 |
| T63708 | 664-675 | RB | denotes | efficiently |
| T61132 | 677-684 | RB | denotes | However |
| T21857 | 684-685 | -COMMA- | denotes | , |
| T14229 | 686-691 | NN | denotes | serum |
| T89468 | 692-696 | IN | denotes | from |
| T75820 | 697-701 | NNS | denotes | bats |
| T4213 | 702-711 | VBN | denotes | immunized |
| T87498 | 712-716 | IN | denotes | with |
| T5484 | 717-726 | JJ | denotes | SARS-lice |
| T47898 | 727-738 | NN | denotes | coronavirus |
| T5732 | 739-745 | NN | denotes | SL-CoV |
| T45225 | 746-749 | NN | denotes | Rp3 |
| T42100 | 750-755 | MD | denotes | could |
| T14407 | 756-759 | RB | denotes | not |
| T21817 | 760-765 | VB | denotes | exert |
| T34384 | 766-770 | JJ | denotes | such |
| T15054 | 771-773 | DT | denotes | an |
| T64476 | 774-780 | NN | denotes | effect |
| T80575 | 782-784 | PRP | denotes | It |
| T5249 | 785-787 | VBZ | denotes | is |
| T88108 | 788-791 | JJ | denotes | due |
| T14481 | 792-794 | TO | denotes | to |
| T48691 | 795-796 | DT | denotes | a |
| T43979 | 797-807 | JJ | denotes | noticeable |
| T25730 | 808-814 | NN | denotes | degree |
| T63462 | 815-817 | IN | denotes | of |
| T72538 | 818-828 | NN | denotes | difference |
| T22468 | 829-831 | IN | denotes | in |
| T50331 | 832-835 | DT | denotes | the |
| T61223 | 836-838 | NN | denotes | S1 |
| T8313 | 839-845 | NN | denotes | domain |
| T42013 | 846-848 | IN | denotes | in |
| T41693 | 849-852 | DT | denotes | the |
| T41576 | 853-855 | NN | denotes | S1 |
| T33017 | 856-862 | NN | denotes | domain |
| T6643 | 863-870 | IN | denotes | between |
| T73200 | 871-874 | DT | denotes | the |
| T38226 | 875-878 | NN | denotes | bat |
| T96665 | 879-885 | NN | denotes | SL-CoV |
| T68744 | 886-889 | NN | denotes | Rp3 |
| T25467 | 890-896 | NN | denotes | strain |
| T80157 | 897-900 | CC | denotes | and |
| T9673 | 901-910 | NN | denotes | SARS-CoV2 |
| T92096 | 912-913 | DT | denotes | A |
| T21466 | 914-924 | JJ | denotes | short-term |
| T18604 | 925-933 | JJ | denotes | moderate |
| T45992 | 934-938 | NN | denotes | dose |
| T31582 | 939-941 | IN | denotes | of |
| T44685 | 942-946 | NN | denotes | IVIG |
| T42097 | 947-955 | VBN | denotes | combined |
| T36053 | 956-960 | IN | denotes | with |
| T48662 | 961-974 | NN | denotes | moderate-dose |
| T22507 | 975-977 | IN | denotes | of |
| T9912 | 978-993 | NNS | denotes | corticosteroids |
| T83835 | 994-999 | MD | denotes | might |
| T7774 | 1000-1007 | VB | denotes | improve |
| T16718 | 1008-1015 | NN | denotes | patient |
| T30604 | 1016-1024 | NNS | denotes | outcomes |
| T91513 | 1026-1033 | NNS | denotes | Studies |
| T81529 | 1034-1038 | VBP | denotes | show |
| T7530 | 1039-1043 | IN | denotes | that |
| T31986 | 1044-1047 | DT | denotes | the |
| T73402 | 1048-1053 | JJ | denotes | viral |
| T42028 | 1054-1057 | NN | denotes | RNA |
| T66238 | 1058-1060 | IN | denotes | of |
| T77066 | 1061-1070 | NN | denotes | SARS-CoV2 |
| T7474 | 1071-1078 | VBZ | denotes | reaches |
| T81899 | 1079-1082 | PRP-DOLLAR- | denotes | its |
| T82598 | 1083-1087 | NN | denotes | peak |
| T40173 | 1088-1094 | IN | denotes | during |
| T31013 | 1095-1098 | DT | denotes | the |
| T16396 | 1099-1104 | JJ | denotes | first |
| T75325 | 1105-1109 | NN | denotes | week |
| T4182 | 1110-1113 | CC | denotes | and |
| T18300 | 1114-1118 | RB | denotes | then |
| T56358 | 1119-1128 | RB | denotes | gradually |
| T76094 | 1129-1138 | VBZ | denotes | decreases |
| T20828 | 1139-1142 | CC | denotes | and |
| T83224 | 1143-1147 | IN | denotes | that |
| T96146 | 1148-1151 | NN | denotes | IgG |
| T47796 | 1152-1155 | CC | denotes | and |
| T69933 | 1156-1159 | NN | denotes | IgM |
| T32800 | 1160-1165 | VBP | denotes | begin |
| T67925 | 1166-1168 | TO | denotes | to |
| T47586 | 1169-1173 | VB | denotes | rise |
| T31692 | 1174-1178 | IN | denotes | from |
| T7968 | 1179-1182 | DT | denotes | the |
| T13466 | 1183-1187 | JJ | denotes | 10th |
| T6862 | 1188-1191 | NN | denotes | day |
| T3983 | 1192-1194 | IN | denotes | so |
| T20802 | 1195-1199 | IN | denotes | that |
| T89923 | 1200-1204 | JJS | denotes | most |
| T68511 | 1205-1213 | NNS | denotes | patients |
| T75930 | 1214-1218 | VBP | denotes | have |
| T84637 | 1219-1229 | JJ | denotes | anti-viral |
| T76069 | 1230-1240 | NNS | denotes | antibodies |
| T50453 | 1241-1243 | IN | denotes | by |
| T78621 | 1244-1247 | DT | denotes | the |
| T91971 | 1248-1252 | JJ | denotes | 14th |
| T55876 | 1253-1256 | NN | denotes | day |
| T58337 | 1258-1265 | JJ | denotes | Passive |
| T80315 | 1266-1278 | NN | denotes | immunization |
| T58229 | 1279-1287 | VBZ | denotes | protects |
| T77600 | 1288-1295 | IN | denotes | against |
| T79174 | 1296-1303 | NN | denotes | disease |
| T49092 | 1303-1304 | -COMMA- | denotes | , |
| T77811 | 1305-1308 | CC | denotes | and |
| T60601 | 1309-1311 | IN | denotes | so |
| T49810 | 1312-1314 | PRP | denotes | it |
| T35724 | 1315-1321 | MD | denotes | should |
| T59058 | 1322-1324 | VB | denotes | be |
| T47054 | 1325-1337 | VBN | denotes | administered |
| T78182 | 1338-1340 | RB | denotes | as |
| T58224 | 1341-1346 | RB | denotes | early |
| T10653 | 1347-1349 | IN | denotes | as |
| T65232 | 1350-1358 | JJ | denotes | possible |
| T7135 | 1359-1363 | WRB | denotes | when |
| T74033 | 1364-1367 | DT | denotes | the |
| T73325 | 1368-1375 | NN | denotes | patient |
| T59206 | 1376-1378 | VBZ | denotes | is |
| T72256 | 1379-1388 | VBN | denotes | diagnosed |
| R96809 | T21817 | T21857 | arg1Of | exert,"," |
| R89296 | T14229 | T89468 | arg1Of | serum,from |
| R41066 | T82598 | T81899 | arg1Of | peak,its |
| R12004 | T7474 | T40173 | arg1Of | reaches,during |
| R27770 | T75325 | T40173 | arg2Of | week,during |
| R1991 | T75325 | T31013 | arg1Of | week,the |
| R44540 | T75325 | T16396 | arg1Of | week,first |
| R33815 | T7474 | T4182 | arg1Of | reaches,and |
| R6989 | T76094 | T4182 | arg2Of | decreases,and |
| R11155 | T2209 | T82418 | arg1Of | Lack,of |
| R18503 | T11435 | T82418 | arg2Of | treatments,of |
| R51383 | T11435 | T17483 | arg1Of | treatments,specific |
| R90414 | T11435 | T58860 | arg1Of | treatments,for |
| R71444 | T97288 | T58860 | arg2Of | COVID-19,for |
| R50736 | T2209 | T14954 | arg1Of | Lack,and |
| R33460 | T54347 | T14954 | arg2Of | process,and |
| R14380 | T54347 | T67635 | arg1Of | process,the |
| R26081 | T29994 | T14560 | arg1Of | time-consuming,very |
| R97110 | T54347 | T29994 | arg1Of | process,time-consuming |
| R16377 | T54347 | T43425 | arg1Of | process,of |
| R86230 | T65584 | T43425 | arg2Of | development,of |
| R67339 | T65584 | T40405 | arg1Of | development,vaccine |
| R14139 | T14954 | T26632 | arg1Of | and,lead |
| R21122 | T87212 | T26632 | arg2Of | us,lead |
| R31512 | T17398 | T26632 | arg3Of | trust,lead |
| R61124 | T17398 | T4319 | arg1Of | trust,to |
| R74536 | T87212 | T17398 | arg1Of | us,trust |
| R77927 | T59832 | T17398 | arg2Of | notions,trust |
| R27833 | T59832 | T39922 | arg1Of | notions,traditional |
| R36058 | T59832 | T79640 | arg1Of | notions,of |
| R86414 | T39982 | T79640 | arg2Of | immunization,of |
| R55870 | T59832 | T68886 | arg1Of | notions,using |
| R4750 | T93112 | T68886 | arg2Of | transfer,using |
| R33115 | T93112 | T59526 | arg1Of | transfer,passive |
| R54690 | T93112 | T2403 | arg1Of | transfer,of |
| R97705 | T67166 | T2403 | arg2Of | immunity,of |
| R58970 | T67166 | T97514 | arg1Of | immunity,humoral |
| R62464 | T78989 | T8460 | arg1Of | immunization,Passive |
| R69010 | T78989 | T37380 | arg1Of | immunization,can |
| R8839 | T87394 | T37380 | arg2Of | done,can |
| R15297 | T78989 | T3292 | arg1Of | immunization,be |
| R65636 | T87394 | T3292 | arg2Of | done,be |
| R93364 | T78989 | T87394 | arg2Of | immunization,done |
| R46683 | T28898 | T83285 | arg2Of | and,using |
| R78223 | T87394 | T83285 | modOf | done,using |
| R68311 | T40394 | T80590 | arg1Of | therapy,plasma |
| R99492 | T40394 | T28898 | arg1Of | therapy,and |
| R45855 | T89662 | T28898 | arg2Of | therapy,and |
| R24570 | T89662 | T56173 | arg1Of | therapy,IVIG |
| R81252 | T43126 | T98086 | arg1Of | Plasma,from |
| R55476 | T4913 | T98086 | arg2Of | patients,from |
| R36046 | T4913 | T85558 | arg2Of | patients,recovered |
| R40089 | T85558 | T54139 | arg1Of | recovered,from |
| R61660 | T65005 | T54139 | arg2Of | COVID-19,from |
| R51784 | T65005 | T70575 | arg1Of | COVID-19,that |
| R23204 | T65005 | T50076 | arg1Of | COVID-19,contains |
| R39436 | T23714 | T50076 | arg2Of | antibodies,contains |
| R48539 | T23714 | T54709 | arg1Of | antibodies,against |
| R30604 | T26763 | T54709 | arg2Of | SARS-CoV2,against |
| R80485 | T43126 | T82790 | arg1Of | Plasma,has |
| R13443 | T72786 | T82790 | arg2Of | shown,has |
| R73284 | T43126 | T72786 | arg1Of | Plasma,shown |
| R26476 | T61880 | T72786 | arg2Of | results,shown |
| R9189 | T61880 | T96449 | arg1Of | results,promising |
| R99456 | T72786 | T36158 | arg1Of | shown,in |
| R10241 | T98710 | T36158 | arg2Of | patients,in |
| R95128 | T98710 | T52661 | arg1Of | patients,with |
| R51321 | T61440 | T52661 | arg2Of | COVID-19,with |
| R94308 | T61440 | T93981 | arg1Of | COVID-19,severe |
| R25978 | T49089 | T56097 | arg1Of | are,Also |
| R75925 | T49089 | T27399 | arg1Of | are,"," |
| R25355 | T46672 | T4016 | arg1Of | SARS-CoV,and |
| R69846 | T5488 | T4016 | arg2Of | SARS-CoV2,and |
| R56468 | T4016 | T49089 | arg1Of | and,are |
| R66400 | T58020 | T49089 | arg2Of | similar,are |
| R85443 | T49089 | T63728 | arg1Of | are,ideally |
| R76775 | T4016 | T58020 | arg1Of | and,similar |
| R27176 | T58020 | T17353 | arg1Of | similar,in |
| R34870 | T63353 | T17353 | arg2Of | and,in |
| R24045 | T84845 | T77583 | arg1Of | structure,the |
| R89244 | T84845 | T63353 | arg1Of | structure,and |
| R75896 | T64776 | T63353 | arg2Of | and,and |
| R32754 | T64776 | T19500 | arg1Of | and,the |
| R22660 | T64776 | T16312 | arg1Of | and,cell |
| R80156 | T64776 | T15071 | arg1Of | and,entry |
| R10698 | T65845 | T64776 | arg1Of | receptor,and |
| R99006 | T5365 | T64776 | arg2Of | protease,and |
| R84947 | T91360 | T61175 | arg1Of | Studies,show |
| R79733 | T18753 | T61175 | arg2Of | are,show |
| R89002 | T18753 | T3464 | arg1Of | are,that |
| R19355 | T71594 | T59411 | arg1Of | serum,from |
| R99410 | T52714 | T59411 | arg2Of | patients,from |
| R4231 | T52714 | T50943 | arg1Of | patients,convalescent |
| R68462 | T52714 | T99070 | arg1Of | patients,SARS |
| R33152 | T71594 | T30344 | arg1Of | serum,and |
| R30321 | T97752 | T30344 | arg2Of | serum,and |
| R36008 | T97752 | T56749 | arg1Of | serum,from |
| R98943 | T81227 | T56749 | arg2Of | rabbits,from |
| R53389 | T81227 | T65088 | arg2Of | rabbits,immunized |
| R71243 | T65088 | T9531 | arg1Of | immunized,with |
| R99439 | T3496 | T9531 | arg2Of | SARS,with |
| R9144 | T30344 | T18753 | arg1Of | and,are |
| R85714 | T22390 | T18753 | arg2Of | able,are |
| R89083 | T18753 | T56305 | arg1Of | are,both |
| R85975 | T30344 | T22390 | arg1Of | and,able |
| R44466 | T72802 | T22390 | arg2Of | neutralize,able |
| R65883 | T72802 | T89303 | arg1Of | neutralize,to |
| R42624 | T30344 | T72802 | arg1Of | and,neutralize |
| R88068 | T57194 | T72802 | arg2Of | SARS-CoV2,neutralize |
| R98416 | T72802 | T63708 | arg1Of | neutralize,efficiently |
| R20107 | T21817 | T61132 | arg1Of | exert,However |
| R14356 | T75820 | T89468 | arg2Of | bats,from |
| R90438 | T75820 | T4213 | arg2Of | bats,immunized |
| R80683 | T4213 | T87498 | arg1Of | immunized,with |
| R84283 | T45225 | T87498 | arg2Of | Rp3,with |
| R40363 | T45225 | T5484 | arg1Of | Rp3,SARS-lice |
| R52004 | T45225 | T47898 | arg1Of | Rp3,coronavirus |
| R42253 | T45225 | T5732 | arg1Of | Rp3,SL-CoV |
| R12583 | T14229 | T42100 | arg1Of | serum,could |
| R59273 | T21817 | T42100 | arg2Of | exert,could |
| R73891 | T21817 | T14407 | arg1Of | exert,not |
| R55295 | T14229 | T21817 | arg1Of | serum,exert |
| R61697 | T64476 | T21817 | arg2Of | effect,exert |
| R37168 | T64476 | T34384 | arg1Of | effect,such |
| R7008 | T64476 | T15054 | arg1Of | effect,an |
| R84281 | T80575 | T5249 | arg1Of | It,is |
| R48932 | T14481 | T5249 | arg2Of | to,is |
| R59166 | T14481 | T88108 | arg1Of | to,due |
| R49189 | T80575 | T14481 | arg1Of | It,to |
| R83662 | T25730 | T14481 | arg2Of | degree,to |
| R5580 | T25730 | T48691 | arg1Of | degree,a |
| R98915 | T25730 | T43979 | arg1Of | degree,noticeable |
| R76787 | T25730 | T63462 | arg1Of | degree,of |
| R87111 | T72538 | T63462 | arg2Of | difference,of |
| R24971 | T25730 | T22468 | arg1Of | degree,in |
| R62451 | T8313 | T22468 | arg2Of | domain,in |
| R85256 | T8313 | T50331 | arg1Of | domain,the |
| R60276 | T8313 | T61223 | arg1Of | domain,S1 |
| R98878 | T8313 | T42013 | arg1Of | domain,in |
| R33107 | T33017 | T42013 | arg2Of | domain,in |
| R73057 | T33017 | T41693 | arg1Of | domain,the |
| R3415 | T33017 | T41576 | arg1Of | domain,S1 |
| R8803 | T33017 | T6643 | arg1Of | domain,between |
| R9501 | T80157 | T6643 | arg2Of | and,between |
| R20867 | T80157 | T73200 | arg1Of | and,the |
| R76744 | T80157 | T38226 | arg1Of | and,bat |
| R55984 | T80157 | T96665 | arg1Of | and,SL-CoV |
| R90227 | T80157 | T68744 | arg1Of | and,Rp3 |
| R8259 | T25467 | T80157 | arg1Of | strain,and |
| R76662 | T9673 | T80157 | arg2Of | SARS-CoV2,and |
| R18836 | T45992 | T92096 | arg1Of | dose,A |
| R5589 | T45992 | T21466 | arg1Of | dose,short-term |
| R26862 | T45992 | T18604 | arg1Of | dose,moderate |
| R55027 | T45992 | T31582 | arg1Of | dose,of |
| R78514 | T44685 | T31582 | arg2Of | IVIG,of |
| R68691 | T44685 | T42097 | arg2Of | IVIG,combined |
| R96826 | T42097 | T36053 | arg1Of | combined,with |
| R77343 | T48662 | T36053 | arg2Of | moderate-dose,with |
| R26632 | T48662 | T22507 | arg1Of | moderate-dose,of |
| R66967 | T9912 | T22507 | arg2Of | corticosteroids,of |
| R63178 | T45992 | T83835 | arg1Of | dose,might |
| R94949 | T7774 | T83835 | arg2Of | improve,might |
| R60813 | T45992 | T7774 | arg1Of | dose,improve |
| R60347 | T30604 | T7774 | arg2Of | outcomes,improve |
| R83757 | T30604 | T16718 | arg1Of | outcomes,patient |
| R94383 | T91513 | T81529 | arg1Of | Studies,show |
| R41169 | T20828 | T81529 | arg2Of | and,show |
| R5555 | T4182 | T7530 | arg1Of | and,that |
| R96158 | T42028 | T31986 | arg1Of | RNA,the |
| R45491 | T42028 | T73402 | arg1Of | RNA,viral |
| R22208 | T42028 | T66238 | arg1Of | RNA,of |
| R47705 | T77066 | T66238 | arg2Of | SARS-CoV2,of |
| R24947 | T42028 | T7474 | arg1Of | RNA,reaches |
| R92880 | T82598 | T7474 | arg2Of | peak,reaches |
| R4189 | T76094 | T18300 | arg1Of | decreases,then |
| R72430 | T76094 | T56358 | arg1Of | decreases,gradually |
| R91830 | T42028 | T76094 | arg1Of | RNA,decreases |
| R76838 | T4182 | T20828 | arg1Of | and,and |
| R68274 | T83224 | T20828 | arg2Of | that,and |
| R25456 | T32800 | T83224 | arg2Of | begin,that |
| R55726 | T96146 | T47796 | arg1Of | IgG,and |
| R80184 | T69933 | T47796 | arg2Of | IgM,and |
| R33698 | T47796 | T32800 | arg1Of | and,begin |
| R15830 | T47586 | T32800 | arg2Of | rise,begin |
| R28653 | T47586 | T67925 | arg1Of | rise,to |
| R29470 | T47796 | T47586 | arg1Of | and,rise |
| R88823 | T47586 | T31692 | arg1Of | rise,from |
| R48219 | T6862 | T31692 | arg2Of | day,from |
| R12080 | T6862 | T7968 | arg1Of | day,the |
| R55206 | T6862 | T13466 | arg1Of | day,10th |
| R96440 | T47586 | T3983 | arg1Of | rise,so |
| R49757 | T75930 | T3983 | arg2Of | have,so |
| R32703 | T3983 | T20802 | arg1Of | so,that |
| R56955 | T68511 | T89923 | arg1Of | patients,most |
| R42193 | T68511 | T75930 | arg1Of | patients,have |
| R8377 | T76069 | T75930 | arg2Of | antibodies,have |
| R81229 | T76069 | T84637 | arg1Of | antibodies,anti-viral |
| R49902 | T75930 | T50453 | arg1Of | have,by |
| R96077 | T55876 | T50453 | arg2Of | day,by |
| R36595 | T55876 | T78621 | arg1Of | day,the |
| R33132 | T55876 | T91971 | arg1Of | day,14th |
| R10212 | T80315 | T58337 | arg1Of | immunization,Passive |
| R37865 | T80315 | T58229 | arg1Of | immunization,protects |
| R45413 | T58229 | T77600 | arg1Of | protects,against |
| R63810 | T79174 | T77600 | arg2Of | disease,against |
| R7289 | T77811 | T49092 | arg1Of | and,"," |
| R99280 | T58229 | T77811 | arg1Of | protects,and |
| R63553 | T47054 | T77811 | arg2Of | administered,and |
| R6815 | T47054 | T60601 | arg1Of | administered,so |
| R52856 | T49810 | T35724 | arg1Of | it,should |
| R8823 | T47054 | T35724 | arg2Of | administered,should |
| R10231 | T49810 | T59058 | arg1Of | it,be |
| R22102 | T47054 | T59058 | arg2Of | administered,be |
| R59603 | T49810 | T47054 | arg2Of | it,administered |
| R34099 | T58224 | T78182 | arg1Of | early,as |
| R76856 | T47054 | T58224 | arg1Of | administered,early |
| R92578 | T58224 | T10653 | arg1Of | early,as |
| R76565 | T65232 | T10653 | arg2Of | possible,as |
| R24478 | T47054 | T7135 | arg1Of | administered,when |
| R67187 | T72256 | T7135 | arg2Of | diagnosed,when |
| R98291 | T73325 | T74033 | arg1Of | patient,the |
| R71258 | T73325 | T59206 | arg1Of | patient,is |
| R13185 | T72256 | T59206 | arg2Of | diagnosed,is |
| R6618 | T73325 | T72256 | arg2Of | patient,diagnosed |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T204 | 236-242 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T205 | 269-275 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T206 | 493-497 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T207 | 545-550 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T208 | 587-592 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T209 | 686-691 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T210 | 1054-1057 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T211 | 1148-1151 | Body_part | denotes | IgG | http://purl.org/sig/ont/fma/fma62872 |
| T212 | 1156-1159 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T199 | 32-40 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T200 | 305-313 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T201 | 347-356 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T202 | 409-417 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T203 | 425-433 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T204 | 438-447 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T205 | 569-573 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T206 | 621-625 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T207 | 654-663 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T208 | 717-721 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T209 | 901-910 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T210 | 1061-1070 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T227 | 0-196 | Sentence | denotes | Lack of specific treatments for COVID-19 and the very time-consuming process of vaccine development lead us to trust traditional notions of immunization using passive transfer of humoral immunity. |
| T228 | 197-268 | Sentence | denotes | Passive immunization can be done using plasma therapy and IVIG therapy. |
| T229 | 269-418 | Sentence | denotes | Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19. |
| T230 | 419-526 | Sentence | denotes | Also, SARS-CoV and SARS-CoV2 are ideally similar in the structure and the cell entry receptor and protease. |
| T231 | 527-676 | Sentence | denotes | Studies show that serum from convalescent SARS patients and serum from rabbits immunized with SARS are both able to neutralize SARS-CoV2 efficiently. |
| T232 | 677-781 | Sentence | denotes | However, serum from bats immunized with SARS-lice coronavirus SL-CoV Rp3 could not exert such an effect. |
| T233 | 782-911 | Sentence | denotes | It is due to a noticeable degree of difference in the S1 domain in the S1 domain between the bat SL-CoV Rp3 strain and SARS-CoV2. |
| T234 | 912-1025 | Sentence | denotes | A short-term moderate dose of IVIG combined with moderate-dose of corticosteroids might improve patient outcomes. |
| T235 | 1026-1257 | Sentence | denotes | Studies show that the viral RNA of SARS-CoV2 reaches its peak during the first week and then gradually decreases and that IgG and IgM begin to rise from the 10th day so that most patients have anti-viral antibodies by the 14th day. |
| T236 | 1258-1389 | Sentence | denotes | Passive immunization protects against disease, and so it should be administered as early as possible when the patient is diagnosed. |